The sexually dimorphic role of smooth muscle cell estrogen receptor alpha in vascular aging
平滑肌细胞雌激素受体α的性二态性在血管衰老中的作用
基本信息
- 批准号:10641912
- 负责人:
- 金额:$ 69.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-10 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AgeAgingAgonistAortaAtomic Force MicroscopyAttenuatedBilateralBindingBlood VesselsCardiovascular DiseasesCardiovascular systemChronicClinicalDataDevelopmentDisease OutcomeEFRACElderlyEstrogen Receptor alphaEstrogen declineEstrogensFemaleFibrosisGoalsHealthHeart DiseasesHeart failureHormone replacement therapyHumanHypertensionIn VitroIsolated systolic hypertensionKnockout MiceKnowledgeLifeLigandsMeasuresMediatingMedicalMolecularMorbidity - disease rateMusMyocardial InfarctionOrganOutcomeOvariectomyPathway interactionsPatternPharmaceutical PreparationsPhysiologic pulsePlayPoly(ADP-ribose) PolymerasesPopulationPostmenopausePremenopauseProceduresProcessPublic HealthReceptor ActivationReceptor SignalingRegulationRenin-Angiotensin-Aldosterone SystemRiskRisk FactorsRoleSex DifferencesSmall Interfering RNASmooth Muscle MyocytesStrokeTestingTissuesType 2 Angiotensin II ReceptorVascular Smooth MuscleWomanagedaging populationarmarterial stiffnesscardiovascular disorder riskcardiovascular risk factorchromatin immunoprecipitationclinically significantexperiencefemale sex hormonegene repressionhuman femaleimprovedin vivoin vivo evaluationinhibitorinnovationmalemenmiddle agemortalitymouse modelnew therapeutic targetnovelpreservationpreventpromoterreceptorreceptor expressionreceptor functionsexsexual dimorphismtherapeutic evaluationtherapeutic targettreatment group
项目摘要
Aging is associated with rising arterial stiffness (AS), an independent risk factor for cardiovascular disease (CVD)
that leads to hypertension, heart attack, stroke, and end organ damage. The development of aging-associated
AS follows a sexually dimorphic pattern of development with women developing AS later in life and women have
higher rates of arterial stiffness-associated CVD such as isolated systolic hypertension and heart failure with
preserved ejection fraction. The molecular mechanisms that contribute to sex differences in the development of
aging-associated AS are unclear. Determination of these mechanisms is an unmet medical need with significant
public health implications. We have shown that aging mice follow a similar pattern of development of AS, with
female mice experiencing a late onset of AS compared to males. Estrogen and estrogen receptor alpha (ERα)
are protective in the premenopausal state, yet the role that estrogen/ERα plays in vascular aging has not been
defined. Recent studies have suggested that unliganded ERα (ERα without the presence of estrogen) may be
detrimental to vascular health and due to the declining levels of estrogen in females with age. Further studies
support that ERα/estrogen negatively regulate poly (ADP-ribose) polymerase-1 (PARP1) and that PARP1
transcriptionally represses the angiotensin II type 2 receptor (AT2R), a protective arm of the renin-angiotensin-
aldosterone system. Our preliminary data demonstrate that: 1) aging female mice develop increased AS later in
life than males; 2) vascular ERα expression rises with age in females, 3) estrogen reduces the binding of PARP1
to the AT2R promoter in female SMC; 4) elderly females have enhanced intrinsic vascular smooth muscle cell
stiffness measured by atomic force microscopy compared to elderly males; 5) in a novel mouse model with ERα
deleted from smooth muscle cell (SMC-ERα-KO), AS is prevented in old females and circulating estrogen
declines, supporting a role for unliganded ERα in arterial stiffening and 6) SMC-ERα-KO mice are protected from
the aging-associated increase in aortic PARP1 and decrease in AT2R. We have proposed three specific aims to
test the novel hypothesis that young females are protected from CVD by estrogen--mediated inhibition of PARP1,
resulting in enhanced AT2R activity and that with advancing age, unliganded SMC-ERα contributes to the
development of arterial stiffening via the promotion of PARP1 and consequential inhibition of AT2R expression
and signaling. SA1 will test the hypothesis in vitro that SMC-ERα regulates the PARP-1/AT2R pathway in human
aortic SMC. SA2 will test the in vivo hypothesis that SMC-ERα regulation of PARP-1/AT2R contributes to sex
differences in AS in aging mice by utilizing our novel SMC-ERα-KO mice in addition to determining the role of
SMC-PARP1 in aging-associated AS with our novel SMC-PARP1-KO mice. SA3 will test the therapeutic potential
of chronic AT2R activation and PARP1 inhibition to ameliorate aging-associated AS in male and female mice.
The long-term goal is to identify sex-specific therapeutic targets to aid in improving arterial stiffness and the
associated CVD outcomes in the aging population.
衰老与动脉僵硬度 (AS) 上升有关,动脉僵硬度 (AS) 是心血管疾病 (CVD) 的独立危险因素
导致高血压、心脏病、中风和终末器官损伤。老龄化相关疾病的发展
AS 遵循性别二态性发展模式,女性在晚年患上 AS,并且女性有
与动脉硬化相关的 CVD 发生率较高,例如孤立性收缩期高血压和心力衰竭
保留射血分数。导致性别发育差异的分子机制
与衰老相关的 AS 尚不清楚。确定这些机制是一项未满足的医疗需求,具有重大意义
公共卫生影响。我们已经证明,衰老小鼠遵循类似的 AS 发展模式,
与雄性小鼠相比,雌性小鼠的 AS 发病较晚。雌激素和雌激素受体α (ERα)
在绝经前状态下具有保护作用,但雌激素/ERα 在血管衰老中的作用尚未明确
定义的。最近的研究表明,未配体的 ERα(不含雌激素的 ERα)可能是
不利于血管健康,并且由于女性雌激素水平随着年龄的增长而下降。进一步深造
支持 ERα/雌激素对聚(ADP-核糖)聚合酶-1 (PARP1) 负调节,并且 PARP1
转录抑制血管紧张素 II 2 型受体 (AT2R),这是肾素-血管紧张素-的保护臂
醛固酮系统。我们的初步数据表明:1)老年雌性小鼠在后期出现 AS 增加
寿命比男性长; 2) 女性血管 ERα 表达随着年龄的增长而升高,3) 雌激素减少 PARP1 的结合
女性 SMC 中的 AT2R 启动子; 4)老年女性内源性血管平滑肌细胞增强
通过原子力显微镜测量的硬度与老年男性进行比较; 5) 在具有 ERα 的新型小鼠模型中
从平滑肌细胞 (SMC-ERα-KO) 中删除,老年女性和循环雌激素可预防 AS
下降,支持未配体 ERα 在动脉硬化中的作用,并且 6) SMC-ERα-KO 小鼠受到保护
与衰老相关的主动脉 PARP1 增加和 AT2R 减少。我们提出了三个具体目标
测试新的假设,即雌激素介导的 PARP1 抑制可保护年轻女性免受 CVD,
导致 AT2R 活性增强,并且随着年龄的增长,未配体的 SMC-ERα 有助于
通过促进 PARP1 并随后抑制 AT2R 表达而导致动脉硬化
和信号。 SA1 将在体外测试 SMC-ERα 调节人类 PARP-1/AT2R 通路的假设
主动脉平滑肌细胞。 SA2 将测试 SMC-ERα 对 PARP-1/AT2R 的调节有助于性的体内假设
通过利用我们的新型 SMC-ERα-KO 小鼠,除了确定衰老小鼠的 AS 的作用外,还研究了 AS 的差异
我们的新型 SMC-PARP1-KO 小鼠在衰老相关 AS 中的 SMC-PARP1。 SA3将测试治疗潜力
慢性 AT2R 激活和 PARP1 抑制可改善雄性和雌性小鼠中与衰老相关的 AS。
长期目标是确定性别特异性治疗目标,以帮助改善动脉僵硬度和
老龄化人口中的相关CVD结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer DuPont其他文献
Jennifer DuPont的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 69.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 69.48万 - 项目类别:
Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 69.48万 - 项目类别:
Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 69.48万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 69.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 69.48万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 69.48万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 69.48万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 69.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 69.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




